These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. [Hot topics in 2017 in oncology and hematology. A selection by the editorial board of Bulletin du Cancer]. Vignot S; André T; Caux C; Bouleuc C; Evrard S; Gonçalves A; Lacroix M; Magné N; Massard C; Mazeron JJ; Orbach D; Rodrigues M; Thariat J; Wislez M; L'Allemain G; Bay JO Bull Cancer; 2018 Jan; 105(1):6-14. PubMed ID: 29269176 [TBL] [Abstract][Full Text] [Related]
24. Precision Oncology: Are We There Yet? EBioMedicine; 2017 Apr; 18():1-2. PubMed ID: 28442127 [No Abstract] [Full Text] [Related]
25. Oncology reimbursement in the era of personalized medicine and big data. Ward JC J Oncol Pract; 2014 Mar; 10(2):83-6. PubMed ID: 24633283 [No Abstract] [Full Text] [Related]
26. Next-Generation Sequencing in Oncology in the Era of Precision Medicine. Blumenthal GM; Mansfield E; Pazdur R JAMA Oncol; 2016 Jan; 2(1):13-4. PubMed ID: 26540172 [No Abstract] [Full Text] [Related]
27. Precision Oncology Framework for Investigation of Exercise As Treatment for Cancer. Jones LW J Clin Oncol; 2015 Dec; 33(35):4134-7. PubMed ID: 26460301 [TBL] [Abstract][Full Text] [Related]
28. Making paediatric precision oncology a reality. The Lancet Oncology Lancet Oncol; 2016 Oct; 17(10):1335. PubMed ID: 27733256 [No Abstract] [Full Text] [Related]
29. Proposal for the creation of a national strategy for precision medicine in cancer: a position statement of SEOM, SEAP, and SEFH. Garrido P; Aldaz A; Vera R; Calleja MA; de Álava E; Martín M; Matías-Guiu X; Palacios J Clin Transl Oncol; 2018 Apr; 20(4):443-447. PubMed ID: 28861725 [TBL] [Abstract][Full Text] [Related]
31. Trends and challenges in immuno-oncology trials. Kiernan B Drugs Today (Barc); 2016 Jul; 52(7):387-93. PubMed ID: 27540597 [TBL] [Abstract][Full Text] [Related]
32. Brave-ish New World--What's Needed to Make Precision Oncology a Practical Reality. MacConaill LE; Lindeman NI; Rollins BJ JAMA Oncol; 2015 Oct; 1(7):879-80. PubMed ID: 26181886 [No Abstract] [Full Text] [Related]
33. Cost-effectiveness considerations with molecular diagnostics in oncology. Brunstein J MLO Med Lab Obs; 2016 May; 48(5):30-1. PubMed ID: 27326449 [No Abstract] [Full Text] [Related]
34. Results of the 2013 American Society of Clinical Oncology National Oncology Census. Hanley A; Hagerty K; Towle EL; Neuss MN; Mulvey TM; Acheson AK J Oncol Pract; 2014 Mar; 10(2):143-8. PubMed ID: 24633290 [TBL] [Abstract][Full Text] [Related]
35. [Contribution and challenges of Big Data in oncology]. Saintigny P; Foy JP; Ferrari A; Cassier P; Viari A; Puisieux A Bull Cancer; 2017 Mar; 104(3):281-287. PubMed ID: 27894504 [TBL] [Abstract][Full Text] [Related]
36. Next-generation sequencing in precision oncology: challenges and opportunities. Kruglyak KM; Lin E; Ong FS Expert Rev Mol Diagn; 2014 Jul; 14(6):635-7. PubMed ID: 24791810 [TBL] [Abstract][Full Text] [Related]
38. Making precision oncology the standard of care. The Lancet Oncology Lancet Oncol; 2017 Jul; 18(7):835. PubMed ID: 28677559 [No Abstract] [Full Text] [Related]
39. Surgical Oncology in the Age of Genomic Medicine. Weber TK Surg Oncol Clin N Am; 2015 Oct; 24(4):xiii-xv. PubMed ID: 26363545 [No Abstract] [Full Text] [Related]
40. Being more precise in assessing the value of precision medicine in breast cancer. Curigliano G Breast; 2016 Oct; 29():186-7. PubMed ID: 27600532 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]